GLP-3 RT 5MG

 Selling fast! Get yours today  Same-day shipping available

$169.99

In stock

Buy 2 Get 1 Free! Add all three items to your cart to receive the discount!
Why this batch

Key highlights

Lyophilized 5 mg vialSupplied as a sterile lyophilized powder in a sealed glass vial for stable, long-term storage.
39-amino-acid multi-receptor peptideA defined synthetic peptide construct engineered to engage three distinct metabolic receptor targets, characterized for identity in every batch.
Independently verifiedTested by an accredited US third-party lab for identity, purity, and concentration.
Research use onlySupplied exclusively for laboratory investigation and development.
Technical data

Product specifications

GLP-3 RT — 5 mg lyophilized vial
Compound ClassSynthetic peptide, triple receptor agonist (GCGR / GIPR / GLP-1R)
Quantity5 mg per vial
AppearanceLyophilized powder, sterile glass vial (diluent not included)
CAS Number2381089-83-2
Chemical FormulaC221H342N46O68
Peptide Backbone39-amino-acid single-chain peptide incorporating non-proteinogenic residues and a fatty-diacid lipidation moiety. Full sequence data available on request via the certificate of analysis.
Molar Mass4,731.33 g/mol
Receptor TargetsGlucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), glucagon-like peptide-1 receptor (GLP-1R)
SynonymsLY3437943, GLP-3 RT
Verified PurityBatch-tested to 99.90% (HPLC); minimum 98%
TermsFor laboratory research use only. Not for human or animal consumption.
View certificates of analysis
Sourcing & quality

Why source GLP-3 RT from Sports Technology Labs

Research peptides vary widely in identity, purity, and actual peptide content between suppliers, which makes independent third-party verification by HPLC and mass spectrometry essential. Sports Technology Labs publishes its certificates of analysis on the website.

99.90%verified batch purity (HPLC)
≥98%minimum purity specification
5 mgpeptide per lyophilized vial
2–8 °Crefrigerated cold-chain storage
Third-party tested & certified

Identity, purity, and concentration verified by MZ Biolabs (Tucson, AZ), an accredited US laboratory.

Lyophilized & cold-stored

Vials are freeze-dried and refrigerated to help preserve peptide stability.

Sterile glass vials, packaged in America

Accurate, verifiable specifications with no discreet payment methods or mislabeling.

60-day money-back guarantee

Transparent business, standard payment methods, no misrepresentation.

Research context

What is GLP-3 RT?

GLP-3 RT (LY3437943) is a synthetic single-chain peptide of approximately 39 amino acids, engineered as a triple receptor agonist that engages the glucagon receptor (GCGR), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon-like peptide-1 receptor (GLP-1R) (ref. 1). It is produced synthetically for laboratory use.

GLP-3 RT is an experimental research compound supplied strictly for laboratory research. Sports Technology Labs makes no claims regarding its effects, and nothing in this listing should be interpreted as describing outcomes in humans or animals.

Regulatory & compliance status

Important regulatory information

Not approved for human use

GLP-3 RT is investigational and has not been approved by the FDA for any therapeutic indication. It is not a dietary supplement, drug, or food, and is not lawful to market for human ingestion.

Anti-doping status

GLP-3 RT is not individually named on the current WADA Prohibited List, but as an unapproved investigational substance it falls under the S0 (Non-Approved Substances) catch-all, and the broader class of GLP-1/GIP/glucagon receptor agonists is under active anti-doping scrutiny.

Legal status for research

In the United States, GLP-3 RT is not a scheduled or controlled substance and may be legally purchased and possessed for laboratory research use.

Our position

Sports Technology Labs are chemical suppliers, not medical providers. We do not condone or encourage consumer use of research compounds.

Citations

Scientific references

  1. Coskun T, et al. LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept. Cell Metabolism, 2022;34(9):1234-1247.
  2. WADA Prohibited List (2026), Section S0: Non-Approved Substances. WADA.org.

Research use only. All products on this website are intended exclusively for laboratory research and development. They are not for human or animal consumption. These statements have not been evaluated by the U.S. Food and Drug Administration, and these products are not intended to diagnose, treat, cure, or prevent any disease.

Additional information

Weight .25 oz
Dimensions 1 × 1 × 1 in